Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 88,334 | 143,428 | 265,453 | 104,641 | 181,101 |
| Marketable Securities | 154,484 | 6,381 | 1,009 | 2,543 | 136,015 |
| Receivables | 42,571 | 2,360 | N/A | N/A | N/A |
| Inventories | 910 | 8,272 | 0 | N/A | N/A |
| Other current assets | 46 | 293 | 2,019 | 1,890 | 1,333 |
| TOTAL | $314,875 | $184,586 | $294,084 | $140,577 | $334,347 |
| Non-Current Assets | |||||
| PPE Net | 114,264 | 137,094 | 146,082 | 143,659 | 82,863 |
| Investments And Advances | 0 | 0 | 891 | 840 | 7,597 |
| Intangibles | 0 | 0 | 17,093 | 20,003 | 1,420 |
| Other Non-Current Assets | 72,759 | 61,253 | 46,302 | 57,277 | 42,683 |
| TOTAL | $187,023 | $198,347 | $210,368 | $221,779 | $134,563 |
| Total Assets | $501,898 | $382,933 | $504,452 | $362,356 | $468,910 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 431,901 | N/A |
| Accounts payable and accrued liabilities | 7,381 | 6,898 | 10,331 | 24,485 | 15,361 |
| Accrued Expenses | 46,838 | 40,580 | 42,708 | 41,825 | 51,387 |
| TOTAL | $61,754 | $54,944 | $58,283 | $500,861 | $368,995 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 104,586 | N/A | 306,349 |
| Other Non-Current Liabilities | 939,792 | 816,199 | 928,176 | 312,068 | 40,537 |
| TOTAL | $939,718 | $816,118 | $1,032,106 | $311,315 | $343,828 |
| Total Liabilities | $1,001,472 | $871,062 | $1,090,389 | $812,176 | $712,823 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,028,111 | 853,442 | 673,952 | 435,836 | 397,911 |
| Common Shares | 101 | 85 | 67 | 42 | 40 |
| Retained earnings | -3,726,646 | -3,375,248 | -2,961,684 | -2,378,488 | -1,961,921 |
| Other shareholders' equity | 29,851 | 2,167 | 1,060 | -2,310 | -1,736 |
| TOTAL | $-499,574 | $-488,129 | $-585,937 | $-449,820 | $-243,913 |
| Total Liabilities And Equity | $501,898 | $382,933 | $504,452 | $362,356 | $468,910 |